Targovax to present and attend at upcoming investor and scientific conferences

On March 8, 2021 Targovax ASA, reported that members of its executive management team is invited to present and participate at upcoming conferences (Press release, Targovax, MAR 8, 2021, View Source [SID1234576177]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Annual Global Life Sciences Conference, virtual
Date: 9 March 2021
Presenter: Øystein Soug (CEO)
Time: 13:00 CET

Carnegie Healthcare Seminar, virtual
Date: 12 March 2021
Presenter: Øystein Soug (CEO)
Time: 12:45 CET

Roth Capital 33rd Annual Conference, virtual
Date: 15-17 March 2021
1×1 meetings

Tumor Myeloid Microenvironment Directed Therapeutics, virtual
Date: 17 March
Presenter: Victor Levitsky (CSO)
Time: 22:45 CET

European Biotech Investor Days 2021, virtual
Date: 7-8 April 2021
Presenter: Øystein Soug (CEO)
Time: To be scheduled